Psychemedics Total Non-Operating Income/Expense 2010-2024 | PMD

Psychemedics total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Psychemedics Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $-1
2022 $0
2021 $-1
2020 $-0
2019 $0
2018 $0
2017 $0
2016 $-0
2015 $-0
2014 $-0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Psychemedics Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-06-30 $0
2024-03-31 $-0
2023-12-31 $-0
2023-09-30
2023-06-30 $-1
2023-03-31 $-0
2022-12-31 $-0
2022-09-30 $-0
2022-06-30 $-0
2022-03-31 $0
2021-12-31 $-1
2021-09-30 $0
2021-06-30
2021-03-31 $-0
2020-12-31 $-0
2020-09-30 $-0
2020-06-30 $-0
2020-03-31 $-0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $-0
2018-09-30 $-0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $-0
2017-03-31 $-0
2016-12-31 $-0
2016-09-30 $-0
2016-06-30 $-0
2016-03-31 $-0
2015-12-31 $-0
2015-09-30 $-0
2015-06-30 $-0
2015-03-31 $-0
2014-12-31 $-0
2014-09-30 $-0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.014B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00